Aarkstore - Hyperlipidemia - Pipeline Review, H2 2014 - PowerPoint PPT Presentation

Loading...

PPT – Aarkstore - Hyperlipidemia - Pipeline Review, H2 2014 PowerPoint presentation | free to download - id: 740508-OWI3M



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Aarkstore - Hyperlipidemia - Pipeline Review, H2 2014

Description:

‘Hyperlipidemia - Pipeline Review, H2 2014’, provides an overview of the Hyperlipidemia’s therapeutic pipeline. For more details : – PowerPoint PPT presentation

Number of Views:12

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Aarkstore - Hyperlipidemia - Pipeline Review, H2 2014


1
Aarkstore - Hyperlipidemia - Pipeline Review, H2
2014
www.aarkstore.com
2
Summary
  • Hyperlipidemia - Pipeline Review, H2 2014,
    provides an overview of the
  • Hyperlipidemias therapeutic pipeline.
  • This Market Research Report provides
    comprehensive information on the therapeutic
  • development for Hyperlipidemia, complete with
    comparative analysis at various stages,
  • therapeutics assessment by drug target, mechanism
    of action (MoA), route of administration
  • (RoA) and molecule type, along with latest
    updates, and featured news and press releases. It
  • also reviews key players involved in the
    therapeutic development for Hyperlipidemia and
  • special features on late-stage and discontinued
    projects.

www.aarkstore.com
www.aarkstore.com
3
Scope
  • - The report provides a snapshot of the
    global therapeutic landscape of Hyperlipidemia-
    The report reviews key pipeline products under
    drug profile section which includes, product
    description, MoA and RD brief, licensing and
    collaboration details other developmental
    activities - The report reviews key players
    involved in the therapeutics development for
    Hyperlipidemia and enlists all their major and
    minor projects- The report summarizes all the
    dormant and discontinued pipeline projects - A
    review of the Hyperlipidemia products under
    development by companies and universities/research
    institutes based on information derived from
    company and industry-specific sources- Pipeline
    products coverage based on various stages of
    development ranging from pre-registration till
    discovery and undisclosed stages- A detailed
    assessment of monotherapy and combination therapy
    pipeline projects- Coverage of the
    Hyperlipidemia pipeline on the basis of target,
    MoA, route of administration and molecule type-
    Latest news and deals relating related to
    pipeline products

www.aarkstore.com
4
Reasons to buy
  • - Provides strategically significant
    competitor information, analysis, and insights to
    formulate effective RD development strategies-
    Identify emerging players with potentially strong
    product portfolio and create effective
    counter-strategies to gain competitive
    advantage- Develop strategic initiatives by
    understanding the focus areas of leading
    companies- Identify and understand important and
    diverse types of therapeutics under development
    for Hyperlipidemia- Plan mergers and
    acquisitions effectively by identifying key
    players of the most promising pipeline- Devise
    corrective measures for pipeline projects by
    understanding Hyperlipidemia pipeline depth and
    focus of Indication therapeutics- Develop and
    design in-licensing and out-licensing strategies
    by identifying prospective partners with the most
    attractive projects to enhance and expand
    business potential and scope- Modify the
    therapeutic portfolio by identifying discontinued
    projects and understanding the factors that drove
    them from pipeline

www.aarkstore.com
5
Table of Contents
  • Introduction Global Markets Direct Report
    Coverage Hyperlipidemia Overview Therapeutics
    Development Pipeline Products for Hyperlipidemia
    - Overview Pipeline Products for Hyperlipidemia
    - Comparative Analysis Hyperlipidemia -
    Therapeutics under Development by Companies
    Hyperlipidemia - Therapeutics under
    Investigation by Universities/Institutes
    Hyperlipidemia - Pipeline Products Glance
    Clinical Stage Products Early Stage Products

www.aarkstore.com
6
List Of Tables
  • Number of Products under Development for
    Hyperlipidemia, H2 2014 Number of Products under
    Development for Hyperlipidemia - Comparative
    Analysis, H2 2014 Number of Products under
    Development by Companies, H2 2014 Number of
    Products under Development by Companies, H2 2014
    (Contd..1) Number of Products under
    Investigation by Universities/Institutes, H2 2014
    Comparative Analysis by Clinical Stage
    Development, H2 2014 Comparative Analysis by
    Early Stage Development, H2 2014 Products under
    Development by Companies, H2 2014Products under
    Development by Companies, H2 2014 (Contd..1)
    Products under Development by Companies, H2 2014
    (Contd..2)

www.aarkstore.com
7
List Of Figures
  • Number of Products under Development for
    Hyperlipidemia, H2 2014 Number of Products under
    Development for Hyperlipidemia - Comparative
    Analysis, H2 2014 Number of Products under
    Development by Companies, H2 2014 Number of
    Products under Investigation by
    Universities/Institutes, H2 2014 Comparative
    Analysis by Clinical Stage Development, H2 2014
    Comparative Analysis by Early Stage Products, H2
    2014 Assessment by Monotherapy Products, H2 2014
    Number of Products by Top 10 Targets, H2 2014
    Number of Products by Stage and Top 10 Targets,
    H2 2014 Number of Products by Top 10 Mechanism
    of Actions, H2 2014

www.aarkstore.com
8
Related Market Research reports
  • Corticosteroid-Responsive Dermatoses - Pipeline
    Review, H1 2014
  • Hematological Tumor - Pipeline Review, H1 2014
  • Inflammation - Pipeline Review, H1 2014
  • Opioid Induced Side Effects - Pipeline Review, H1
    2014
  • Skin Infections - Pipeline Review, H1 2014

www.aarkstore.com
9
Related Market Research reports
  • Restenosis - Pipeline Review, H1 2014
  • Tauopathies - Pipeline Review, H1 2014
  • Nasopharyngitis (Common Cold) - Pipeline Review,
    H1 2014
  • Mucopolysaccharidosis III (MPS III) (Sanfilippo
    Syndrome) - Pipeline Review, H1 2014
  • Chemotherapy Induced Peripheral Neuropathy -
    Pipeline Review, H1 2014

www.aarkstore.com
10
Aarkstore - Hyperlipidemia - Pipeline Review, H2
2014
Format Price
PDF 2000
Site Licence 4000
Enterprise Wide Licence  6000
www.aarkstore.com
11
Contact Us
  • Office
  • Office No. - 809, 8th Floor,
  • B-Wing, Mahaavir Icon, 
  • Plot No.- 89 90, Sector-15,
  • CBD-Belapur, Navi Mumbai 400614, 
  • Maharashtra, India.
  • 24/7 Online Support 91 9987295242
  • General Inquiries 91 - 22 2756 4953
  • You Can Visit http//www.aarkstore.com
  • OR Mail us at contact_at_aarkstore.com
  • Blog http//www.aarkstore.com/blog/
  • Conference http//conference.aarkstore.com/
  • News http//www.aarkstore.com/news

www.aarkstore.com
About PowerShow.com